Investments
20Portfolio Exits
4Funds
2Service Providers
1About Tate & Lyle Ventures
Tate & Lyle Ventures consists of two venture capital funds, a £25 million venture capital fund launched in 2006 (and now fully committed) and an active £30 million fund focused on investing in high growth companies in the areas of food sciences and technologies. Both funds are structured and managed as Limited Partnerships enabling them to be managed as independent venture capital funds. Tate & Lyle Ventures is structured in this way to enable objective investment decisions to be made rapidly and independently based on best practice in the venture capital industry.
Tate & Lyle Ventures Headquarter Location
1 Kingsway
London, England, WC2B 6AT,
United Kingdom
Latest Tate & Lyle Ventures News
Jul 27, 2020
Zacks Investment Research Lowers Tate & Lyle (OTCMKTS:TATYY) to Strong Sell Posted by Erica Schwartz on Jul 27th, 2020 Daily Ratings & News for Tate & Lyle Complete the form below to receive the latest headlines and analysts' recommendations for Tate & Lyle with our free daily email newsletter: Zacks Investment Research lowered shares of Tate & Lyle (OTCMKTS:TATYY) from a buy rating to a strong sell rating in a report issued on Thursday, Zacks.com reports. According to Zacks, “Tate & Lyle Ventures and Agri Investment Fund have co-led a 3.5m investment into Fugeia, a newly formed functional food technology business with a focus on gut health. “ Get Tate & Lyle alerts: Other equities analysts have also issued reports about the stock. Barclays reissued an overweight rating on shares of Tate & Lyle in a research report on Thursday, May 28th. Jefferies Financial Group raised shares of Tate & Lyle from a hold rating to a buy rating in a research report on Tuesday, March 31st. ValuEngine lowered shares of Tate & Lyle from a hold rating to a sell rating in a research report on Wednesday, May 27th. Investec lowered shares of Tate & Lyle from a hold rating to a sell rating in a research report on Wednesday, May 6th. Finally, Berenberg Bank reaffirmed a hold rating on shares of Tate & Lyle in a report on Wednesday, May 6th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $39.00. TATYY opened at $34.28 on Thursday. Tate & Lyle has a 12-month low of $23.57 and a 12-month high of $42.50. The company has a current ratio of 2.23, a quick ratio of 1.33 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $4.01 billion, a PE ratio of 11.58 and a beta of 0.78. The firm has a 50 day moving average of $33.53 and a two-hundred day moving average of $35.27. About Tate & Lyle Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products.
Tate & Lyle Ventures Investments
20 Investments
Tate & Lyle Ventures has made 20 investments. Their latest investment was in Zymtronix as part of their Unattributed VC on February 2, 2020.
Tate & Lyle Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
2/5/2020 | Unattributed VC | Zymtronix | Yes | 1 | ||
8/12/2019 | Series C | Nutriati | $12.7M | No | 5 | |
12/19/2018 | Series A | Changing Health | $3.79M | Yes | 4 | |
6/13/2018 | Series C | |||||
5/18/2018 | Series B |
Date | 2/5/2020 | 8/12/2019 | 12/19/2018 | 6/13/2018 | 5/18/2018 |
|---|---|---|---|---|---|
Round | Unattributed VC | Series C | Series A | Series C | Series B |
Company | Zymtronix | Nutriati | Changing Health | ||
Amount | $12.7M | $3.79M | |||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 1 | 5 | 4 |
Tate & Lyle Ventures Portfolio Exits
4 Portfolio Exits
Tate & Lyle Ventures has 4 portfolio exits. Their latest portfolio exit was Nutriati on May 03, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
5/3/2022 | Acquired | 3 | |||
Date | 5/3/2022 | |||
|---|---|---|---|---|
Exit | Acquired | |||
Companies | ||||
Valuation | ||||
Acquirer | ||||
Sources | 3 |
Tate & Lyle Ventures Acquisitions
1 Acquisition
Tate & Lyle Ventures acquired 1 company. Their latest acquisition was BioFilm on January 03, 2008.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/3/2008 | Other | $6.17M | Acq - Fin | 1 |
Date | 1/3/2008 |
|---|---|
Investment Stage | Other |
Companies | |
Valuation | |
Total Funding | $6.17M |
Note | Acq - Fin |
Sources | 1 |
Tate & Lyle Ventures Fund History
2 Fund Histories
Tate & Lyle Ventures has 2 funds, including Tate & Lyle Ventures.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
4/1/2006 | Tate & Lyle Ventures | Early-Stage Venture Capital | Closed | $46M | 1 |
Tate & Lyle Ventures II |
Closing Date | 4/1/2006 | |
|---|---|---|
Fund | Tate & Lyle Ventures | Tate & Lyle Ventures II |
Fund Type | Early-Stage Venture Capital | |
Status | Closed | |
Amount | $46M | |
Sources | 1 |
Tate & Lyle Ventures Service Providers
1 Service Provider
Tate & Lyle Ventures has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Counsel | General Counsel |
Service Provider | |
|---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource
Tate & Lyle Ventures Team
2 Team Members
Tate & Lyle Ventures has 2 team members, including current Managing Partner, David Atkinson.
Name | Work History | Title | Status |
|---|---|---|---|
David Atkinson | Managing Partner | Current | |
Simon Barnes | Managing Partner | Current |
Name | David Atkinson | Simon Barnes |
|---|---|---|
Work History | ||
Title | Managing Partner | Managing Partner |
Status | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.